Asimov
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $180M
Investors
- 9
About Asimov
Asimov, Inc.Asimov, Inc. focuses on synthetic biology, establishing its headquarters in Boston, US in 2017. The company was co-founded by Alec Nielsen, Alexander Levesque, Raja Srinivas, and Rodrigo Tadewald.Asimov is focused on delivering innovative solutions in the field of synthetic biology, particularly through its flagship product offerings which include advanced genetic engineering tools and platforms. These tools aim to facilitate the design, construction, and testing of new biological systems, thereby addressing complex challenges in various industries, including healthcare, agriculture, and environmental sustainability. The company’s products are designed for a diverse clientele, including research institutions, biotechnology firms, and agricultural businesses, with a keen emphasis on enabling end-users to develop targeted therapies, sustainable crop varieties, and bioremediation strategies.The revenue model of Asimov is structured around B2B transactions, where the company engages in partnerships with research institutions and commercial enterprises. The transactions typically involve licensing agreements and collaborative projects that leverage Asimov's proprietary technology for mutual benefit. The pricing structure encompasses various tiers based on the scope and scale of the services rendered, including options for subscription-based access to their platforms and one-time fees for specific project collaborations. The company aims to develop new products likely focused on these areas, although specific release dates have not been disclosed. Additionally, Asimov intends to expand its operations into new markets within North America, Europe, and Asia, targeting growth by mid-2023. This strategic direction is aimed at reinforcing its existing capabilities and tapping into emerging opportunities in synthetic biology.
Who invested in Asimov
9 investors across 2 rounds
See all investors in Asimov
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Asimov
Who invested in Asimov?
Asimov has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Asimov raised?
Asimov has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Asimov last raise money?
Asimov's most recent round on record is a Series B, in Aug 2021.
What does Asimov do?
Asimov is a biotechnology company.
Where is Asimov headquartered?
Asimov is headquartered in Boston, US.
Which VCs invest in companies like Asimov?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Asimov's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Asimov? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.